Semin Plast Surg 2021; 35(03): 159-163
DOI: 10.1055/s-0041-1731462
Review Article

When Benign Becomes Cancer: Malignant Degeneration of Chronic Inflammation

Authors

  • Christopher Conlon

    1   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
  • Lauren Pupa

    2   School of Medicine, Baylor College of Medicine, Houston, Texas
  • Edward M. Reece

    1   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
    3   Division of Plastic Surgery, Texas Children's Hospital, Houston, Texas
  • Carrie K. Chu

    4   Department of Plastic Surgery, MD Anderson Cancer Center, University of Texas, Houston, Texas
  • Jessie Z. Yu

    1   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
  • Joshua Vorstenbosch

    5   Division of Plastic Surgery, McGill University, Montreal, Canada
  • Sebastian Winocour

    1   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
Preview

Abstract

Chronic inflammation, long implicated in the genesis of malignancy, is now understood to underlie an estimated 25% of all cancers. The most pertinent malignancies, to the plastic surgeon, associated with the degeneration of chronic inflammation include Marjolin's ulcer, breast implant-associated large cell lymphoma, radiation-induced sarcoma, and Kaposi's sarcoma. The cellular and genetic damage incurred by a prolonged inflammatory reaction is controlled by an increasingly understood cytokinetic system. Advances in understanding the chronic inflammatory cascade have yielded new therapeutics and therapeutic targets.



Publication History

Article published online:
06 July 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA